MedCap AB (OSTO:MCAP) Total Stockholders Equity: kr1,586 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:MCAP MedCap AB OSTO:MCAP
96 GF Score
Price kr566.50
GF Value kr571.29
Valuation Fairly Valued
View Full Analysis

What is MedCap AB Total Stockholders Equity?

MedCap AB OSTO:MCAP +1.16% 96 Total Stockholders Equity is kr1,586 Mil as of Jun. 2026. GuruFocus rates OSTO:MCAP with a GF Score™ of 96/100 and a GF Value™ of kr571.29 (Fairly Valued).

MedCap AB's Total Stockholders Equity for the quarter that ended in Jun. 2026 was kr1,586 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. MedCap AB's Book Value per Share for the quarter that ended in Jun. 2026 was kr105.91. The ratio of a company's debt over equity can be used to measure how leveraged this company is. MedCap AB's Debt-to-Equity for the quarter that ended in Jun. 2026 was 0.29.


MedCap AB  (OSTO:MCAP) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

MedCap AB's Book Value per Share for the quarter that ended in Jun. 2026 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

MedCap AB's Debt-to-Equity for the quarter that ended in Jun. 2026 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MedCap AB Total Stockholders Equity Related Terms


MedCap AB Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for MedCap AB's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedCap AB Total Stockholders Equity Chart

MedCap AB Annual Data
Trend Apr16 Apr17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 696.00 856.30 1,022.90 1,282.00 1,452.10

MedCap AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,356.40 1,399.60 1,452.10 1,525.60 1,586.10
OSTO:MCAP
96GF Score
MedCap AB OSTO:MCAP
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of kr1,586 Mil mean?
MedCap AB (OSTO:MCAP) has a Total Stockholders Equity of kr1,586 Mil as of Jun. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for MedCap AB and its competitors.
Is MedCap AB's Total Stockholders Equity too high?
MedCap AB's current Total Stockholders Equity is kr1,586 Mil. Overall, MedCap AB has a GF Score™ of 96/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does MedCap AB's Total Stockholders Equity compare to ABT and SYK?
MedCap AB's Total Stockholders Equity of kr1,586 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Medical Devices & Instruments company?
A good Total Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for MedCap AB and its competitors. MedCap AB's current Total Stockholders Equity is kr1,586 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedCap AB stock overvalued right now?
Based on GuruFocus' analysis, MedCap AB (OSTO:MCAP) is currently considered Fairly Valued. The stock's GF Value™ is kr571.29, compared to a current price of kr566.50 — trading 0.8% below its estimated fair value. The current Total Stockholders Equity is kr1,586 Mil. MedCap AB's overall GF Score™ is 96/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For MedCap AB (OSTO:MCAP), the current Total Stockholders Equity is kr1,586 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MedCap AB (OSTO:MCAP) Overvalued in 2026?

Based on GuruFocus' analysis, MedCap AB stock appears to be undervalued. The current stock price of kr566.50 is trading 0.8% below its estimated GF Value™ of kr571.29. GuruFocus considers MedCap AB to be Fairly Valued.

Key valuation signals for OSTO:MCAP:

  • Total Stockholders Equity: kr1,586 Mil
  • GF Value™: kr571.29 vs. price of kr566.50 (0.8% below fair value)
  • GF Score™: 96/100

No single metric tells the full story. See the OSTO:MCAP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MedCap AB Business Description

Other Exchanges MCAPs:UK61MA:Germany
Address Sundbybergsvagen 1, Solna, SWE, 171 73
MedCap AB acquires and develops profitable, market-leading niche companies in the Nordic life science industry. It is diversified into two business areas namely Medical technology and Specialist medicines. Medical Technology mainly develops and sells various medical technology products and services. Its Specialist medicines develop and sell medicines within the regulatory classes of registered, extemporaneous and licensed medicines.
96GF Score

Get the complete analysis for OSTO:MCAP

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr566.50
Price
kr571.29
GF Value